C-reactive protein in psoriasis: a review of the literature

Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab

(2013) Viviana Lora et al.   IMMUNOLOGIC RESEARCH

Principal Determinants of the Length of Remission of Psoriasis Vulgaris After Topical, NB-UVB, and PUVA Therapy

(2012) Susana Coimbra et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis

(2012) J. Romaní et al.   BRITISH JOURNAL OF DERMATOLOGY

Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab

(2012) P. Gisondi et al.   BRITISH JOURNAL OF DERMATOLOGY

Inflammation, Atherosclerosis, and Psoriasis

(2012) David Siegel et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept

(2011) A. Kanelleas et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients

(2011) Murat Usta et al.   CLINICAL BIOCHEMISTRY

High-sensitivity C-reactive protein in psoriasis

(2011) Nuzhatun Nisa et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study

(2011) S. Boehncke et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis Therapy and Cardiovascular Risk Factors

(2010) Susana Coimbra et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Impaired aortic elastic properties in normotensive patients with psoriasis

(2010) Idris Ardic et al.   BLOOD PRESSURE

A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis

(2010) C.L. Martyn-Simmons et al.   BRITISH JOURNAL OF DERMATOLOGY

Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy

(2010) S Coimbra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis

(2010) V. Chandran et al.   RHEUMATOLOGY

Update on Biomarkers in Psoriatic Arthritis

(2010) Vinod Chandran et al.   Current Rheumatology Reports

Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease

(2009) Susana Coimbra et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy

(2009) S Coimbra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis

(2008) B. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY

Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level

(2008) Andrys Ctirad et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice

(2008) C. D. Poole et al.   RHEUMATOLOGY

A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing

(2008) Jeffrey D McBride et al.   JOURNAL OF NANOBIOTECHNOLOGY